2m 2m 2m 2m 2m 2m 2m
Rein Therap (RNTX)
NASDAQ
$0.75+$0.009 (+1.17%)
Price as of Aug 03, 2026 6:16 PM EDT- $63.1MMarket Cap
- -33.57%1-Year Change
- BiotechnologyIndustry
Rein Therap (RNTX)
$0.75+$0.009 (+1.17%)
RNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.74 | ||
Change | -$0.03 (-3.98%) | ||
Open | $0.81 | ||
High | $0.81 | ||
Low | $0.73 | ||
Previous Close | $0.77 | ||
Volume | 391,662 | ||
30-Day Average Volume | 411,866 | ||
1-Week Change | -6.81% | ||
1-Month Change | -29.10% | ||
1-Year Change | -33.57% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 85.5M | ||
Total Assets | $26.3M | ||
Market Cap | $63.1M | ||
Enterprise Value | $63.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$5.8M | ||
EBITDA | -$5.8M | ||
Net Working Capital | -$8.2M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue